Puwan Campus Nuclear Medicine Department

The Department of Nuclear Medicine of the Second Hospital of Dalian Medical University is a comprehensive clinical department integrating medical care, teaching, and research. It is a master's degree-granting site for Imaging Medicine and Nuclear Medicine at Dalian Medical University. The department currently has 1 master's supervisor, 3 professors, and 1 associate professor. It has completed multiple national, provincial, and municipal research projects and published more than 10 papers in SCI-indexed and national core journals.

The Department of Nuclear Medicine at the Puwan Campus upholds the fine tradition of the nuclear medicine professionals of the Second Hospital of Dalian Medical University, characterized by professional ethics, advanced expertise, and excellence. With radionuclide imaging diagnosis and therapy as its specialty, the department has a highly skilled and highly qualified professional technical team. It is currently equipped with major and medium-sized devices, including the Siemens Symbia Intevo Bold SPECT/CT, Horizon-Wi dual-energy X-ray bone densitometer, and HH6008 thyroid function analyzer. The department routinely performs whole-body bone imaging, renal dynamic imaging, thyroid static imaging, myocardial perfusion imaging, pulmonary perfusion imaging, gastrointestinal bleeding imaging, and thyroid function testing; “Yunke” treatment for hyperthyroid exophthalmos and rheumatoid arthritis; 90Y applicator treatment for skin diseases; 131I treatment for thyroid diseases; and 89Sr treatment for bone metastases, among other diagnostic and therapeutic procedures.

Radionuclide therapy is a traditional specialty of the department, which is also one of the earliest institutions in China to provide this treatment. Radioactive iodine has been used to cure thousands of patients with hyperthyroidism, and the department has developed a systematic and individualized method for determining the 131I dose. This method is simple and safe, with a low recurrence rate and few complications, and the cure rate exceeds 95%. The radionuclide therapy ward mainly provides 131I treatment for differentiated thyroid cancer. The ward implements standardized and information-based management and is equipped with an independent video ward-round system, a family visiting system, and comprehensive radiation protection facilities. The ward has been humanely designed and carefully arranged, offering a beautiful, warm, comfortable, and safe environment that helps patients overcome psychological tension and successfully complete the treatment period.

The high-quality diagnosis and treatment provided by the Department of Nuclear Medicine at the Puwan Campus have earned the trust of many patients. We warmly welcome patients to visit our department and will make every effort to provide you with satisfactory services.